RxDoctor Payments Data

Kay McDaniel

Family · Vicksburg, MSNPI 1538100144

Payments from drug & device makers

$1,314in general payments, 2019–2025

Across 77 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$342
  • Novo Nordisk$189
  • Astellas Pharma US Inc$135
  • Bayer$104
  • Boehringer Ingelheim$66
  • Cvrx, Inc.$61
  • plus $417 from 12 others

What the payments were for

  • Food & beverage$1,314100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,314 in reported general payments places this provider in the 70th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$119,842
Medicare patients
231
Services billed
4,020

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin32$39,350
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$36,928
OzempicSemaglutide29$33,954
TrulicityDulaglutide24$26,518
MyrbetriqMirabegron24$21,835
JanuviaSitagliptin Phosphate14$21,810
TradjentaLinagliptin24$15,571
LinzessLinaclotide16$8,916
MounjaroTirzepatide11$7,926
XareltoRivaroxaban12$7,578
Tresiba Flextouch U-100Insulin Degludec12$5,406
PremarinEstrogens, Conjugated16$4,719
Rosuvastatin Calcium172$2,114
PaxlovidNirmatrelvir/Ritonavir12$1,429
SynthroidLevothyroxine Sodium17$1,404

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$66$54,92056 claims
GSKTrelegy Ellipta$36$36,92838 claims
Lilly USA, LLCTrulicity, Mounjaro$31$34,44435 claims
Novo NordiskOzempic$189$33,95429 claims
Astellas Pharma US IncMyrbetriq$135$21,83524 claims
MerckJanuvia$32$21,81014 claims
AbbVieLinzess, Synthroid$43$10,32133 claims
PfizerPremarin, Paxlovid$39$6,14828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,007 family providers in Mississippi.

Other family in Vicksburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →